I am a business minded scientist seeking opportunities to partner with innovators who are patient-centric, for deeply impactful and translational discoveries. I am a freshly minted PhD year with 7 years of my small molecule expertise, developing and identifying targets for future therapeutics. My dissertation work focuses on novel bioavailable small molecule that inhibits a poorly understood signaling pathway, which I showed is critical in the pathogenesis of metastasis through leaveraging electronic health record- genotype database at Vanderbilt. I have managed individuals and larger teams, exemplified in the successful publication of a book that I co-edited, which was authored by lea...